| 李超,许焱,高婷,等.2020年中国与韩国和日本肝癌发病和死亡的比较分析[J].中国临床保健杂志,2024,27(2):206-209. |
| 2020年中国与韩国和日本肝癌发病和死亡的比较分析 |
| Comparison of liver cancer incidence and mortality in China,Republic of Korea and Japan in 2020 |
| 投稿时间：2024-03-02 |
| DOI：10.3969/J.issn.1672-6790.2024.02.014 |
| 中文关键词: 肝肿瘤 发病率 病死率 中国 韩国 日本 |
| 英文关键词: Liver neoplasms Incidence Mortality China Republic of Korea Japan 〖FL |
| 基金项目:中国医学科学院医学与健康科技创新工程项目(2021-I2M-1-012) |
|
| 摘要点击次数: 712 |
| 全文下载次数: 603 |
| 中文摘要: |
| 目的 分析2020年中国肝癌发病、死亡情况,并比较韩国、日本的肝癌负担,为我国进一步完善肝癌的防治策略提供依据。方法 从GLOBOCAN 2020提取中国、韩国及日本的肝癌发病及死亡相关数据,分析并比较不同性别、年龄别肝癌发病率和死亡率差异。结果 2020年中国肝癌新发病例410 038例,发病率为28.3/10万(男性40.8/10万,女性15.2/10万),世标率18.2/10万。韩国肝癌新发病例14 788例,发病率28.8/10万(男性42.6/10万,女性15.1/10万),世标率14.3/10万。日本肝癌新发病例45 663例,发病率为36.1/10万(男性48.3/10万,女性24.4/10万),世标率10.4/10万。2020年中国因肝癌死亡病例391 152例,病死率27.0/10万(男性38.8/10万,女性14.6/10万),世标率17.2/10万。韩国肝癌死亡病例11 158例,病死率21.8/10万(男性31.6/10万,女性11.9/10万),世标率9.9/10万。日本肝癌死亡病例28 155例,病死率22.3/10万(男性29.4/10万,女性15.4/10万),世标率4.8/10万。结论 我国是肝癌高发地区,相较于东亚邻国韩国和日本,我国肝癌发病及病死年龄更早。应针对不同性别、年龄组以及不同地区,制订相应的肝癌防治策略。 |
| 英文摘要: |
| Objective To analyze the incidence and mortality of liver cancer in China in 2020,and to compare the burden of liver cancer in Republic of Korea and Japan,so as to provide basis for further improving the prevention and treatment strategies of liver cancer in China.Methods The incidence and mortality data of liver cancer in China,Republic of Korea and Japan were extracted from GLOBOCAN 2020 and analyzed by gender and age.Results In 2020,there were 410 038 new cases of liver cancer in China,with a crude incidence rate of 28.3 per 100 000 (male 40.8 per 100 000,female 15.2 per 100 000) and Age Standard Rate World (ASR World) of 18.2 per 100 000.There were 14 788 new cases of liver cancer in Republic of Korea,with a crude incidence rate of 28.8 per 100 000 (male 42.6 per 100 000,female 15.1 per 100 000) and ASR World of 14.3 per 100 000.There were 45 663 new cases of liver cancer in Japan,with a crude incidence rate of 36.1 per 100 000 (male 48.3 per 100 000,female 24.4 per 100 000) and ASR World of 10.4 per 100 000.In 2020,a total of 391 152 cases died of liver cancer in China,with a crude mortality rate of 27.0 per 100 000 (male 38.8 per 100 000,female 14.6 per 100 000) and ASR World of 17.2 per 100 000.A total of 11 158 cases died of liver cancer in China,with a crude mortality rate of 21.8 per 100 000 (male 31.6 per 100 000,female 11.9 per 100 000) and ASR World of 9.9 per 100 000.A total of 28 155 cases died of liver cancer in China,with a crude mortality rate of 22.3 per 100 000 (male 29.4 per 100 000,female 15.4 per 100 000) and ASR World of 4.8 per 100 000.Conclusions China has a high incidence of liver cancer.Compared with Republic of Korea and Japan,the onset and death of liver cancer in China are earlier.The strategies for liver cancer prevention and treatment should be further strengthened according to different genders,age groups and regions. |
|
查看全文
|
| 关闭 |
|
|
|